Florian Eichhorn
University Hospital Heidelberg
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Florian Eichhorn as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05825625 · NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKingInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · active not recruiting · Non-small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:00 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience.Lung Cancer · 202173 citationsRCR 3.1
- 60 citationsRCR 2.1
- Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: results of the NEOMUN trial.J Immunother Cancer · 20256 citationsRCR 1.0
- 0 citationsRCR 0.0